World Bio-Mems & Microfluidics Market Forecasts 2017-2027

LONDON, August 9, 2017 /PRNewswire/ --

Revenue Prospects by Type (Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors), Application (Diagnostic, Therapeutic, Tissue Engineering), End-User (Pharmaceutical Industry, Hospitals, Research Centres) and Geography

Bio-MEMS and Microfluidics - our new study reveals trends, R&D progress, and predicted revenues
Where is the Bio-MEMS and Microfluidics market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Discover how to stay ahead
Our 206-page report provides 204 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 13 Product Types, 3 Applications and 3 End Users.

Global Bio-MEMS & Microfluidics Market segments, by Type
• Implantable Bio-MEMS

• Biosensors:
• Gyroscopes
• Stents
• Drug Delivery Devices
• Biochips
• Accelerometers

• Injectable Bio-MEMS:
• Microneedles
• Micromodules

• Other Devices:
• Inhalers
• Catheters
• Micro motors

Global Bio-MEMS & Microfluidics Market segments, by Application
• Diagnostics
• Therapeutics
• Tissue Engineering
• Others

Global Bio-MEMS & Microfluidics Market segments, by End-User
• Pharmaceutical Industry
• Hospitals
• Research Centres
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 Regional & 17 leading national markets:
• North America:
• The US
• Mexico
• Canada

• South America:
• Brazil
• Argentina
• Paraguay
• Bolivia
• Rest of South America

• Europe:
• Germany
• France
• The UK
• Italy
• Spain
• Rest of Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia
• Thailand
• Rest of Asia-Pacific

• Rest of the World:
• Middle East
• Africa
• Other Countries

The report also includes profiles and forecasts for some of the leading companies in the Bio-MEMS and Microfluidics market, with a focus on these segments of the companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth:
Overall world revenue for Bio-MEMS and Microfluidics will surpass $2.8bn in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing prevalence of neurological conditions, increase in diagnostic procedures in emerging economies and increasing ageing population will increase sales to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Bio-MEMS and Microfluidics Market report helps you
In summary, our 206-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the world Bio-MEMS and Microfluidics market and 2 different segmentations, with 13 product categories, 3 applications and 3 end users - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 17 of the leading national markets - US, Mexico, Canada, Brazil, Argentina, Paraguay, Bolivia, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Thailand
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Bio-MEMS and Microfluidics market and leading companies. You find data, trends and predictions.

Get our report today World Bio-MEMS & Microfluidics Market Forecasts 2017-2027 Revenue Prospects by Type (Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors), Application (Diagnostic, Therapeutic, Tissue Engineering), End-User (Pharmaceutical Industry, Hospitals, Research Centres) and Geography. Avoid missing out - get our report now.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com  or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/1948/World-Bio-MEMS-Microfluidics-Market-Forecasts-2017-2027

List of Companies:  

Abbott Diagnostics

Abbott Laboratories Inc

Affymetrix

Affymetrix

Akonni Biosystems

Albright Technologies

Aline Inc

Applied BioPhysics

Aquula

Arcxis Biotechnologies

ArrayJet

Artemis Health

Axis-Shield

Axxicon

Baebies

Bartels Mikrotechnik

Becton, Dickinson and Company

BellBrook Laboratories

Biodetection instruments

Biodot

BiofluidiX

BioForce Nanosciences

Biolithic

BioMicro Systems

Bionas

Bioscale

Biosite

Biosurfit

BioTray

BioVitesse

Boehringer Ingelheim

Boston Microfluidics

Boston Scientific Corporation

Bürkert Fluid Control Systems

Cambridge Biomagnetics

Cambridge Consultants

Capilix

CapitalBio Corporation

Carbo Analytics

CardioMEMS

Cellanyx

Cellectricon

Cellix

Celula

Cepheid

Cetoni

CfBI

Chiral Photonics

CiDRA Precision Services

Claros Diagnostics

Clondiag

CMC Microsystems

CorSolutions

Coventor

Creative MicroSystems

Crospon

CSEM

Cyclofluidic

Cynvenio

Cytocentrics Bioscience

Cytonome

Cytoo

Daktari Diagnostics

Dalsa

Danaher Corporation

Debiotech

Deltadot

DEOS Labs

Design  Solutions

Diagnostics for All

Diagnoswiss

Digilab Globa

DNA Electronics

Dolomite Microfluidics

Drop-Tech

Dyconex

EBB Microparts

F. HOFFMANN-LA ROCHE AG

ForteBio

Fraunhofer-IMS

Fraunhofer-IMS

Johnson & Johnson Ltd.

Medtronic PLC

Nova Biomedical

Nova Medical

Pall ForteBio

Roche Diagnostics

Thermo Fisher Scientific Inc

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com